Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer
Clinical trial NCT01003938 · TERMINATED
Trial details
- NCT number
- NCT01003938
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2012-09-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.